Table 3.
Authors | Patients Number (n) | Kit Used | Indication | Amount Given (ml) |
---|---|---|---|---|
Molina et al. [10] | 19 | not specified/single centrifugation | refractory endometrium | 1.0 |
Zadehmodarres et al. [11] | 10 | not specified/double centrifugation | refractory endometrium | 0.5 |
Tehraninejad et al. [12] | 42 | not specified/double centrifugation | refractory endometrium | 1.0 |
Aghajanova et al. [13] | 6 | Magellan Autologous Platelet Separator System | Asherman’s syndrome | 1.0 |
Farimani et al. [14] | 19 | not specified | poor ovarian response | 2.0 |
Morelli et al. [15] | 10 | allogenic platelet gel | wound healing | not specified |
Goldstein et al. [16] | 29 | Magellan Autologous Platelet Separator System | lichen sclerosus | 5.0 |
Sukgen et al. [17] | 32 | not specified | female sexuality | 11.0 |
Streit- Ciećkiewicz et al. [18] | 16 | Arthrex Angel System | vesicovaginal fistula | 4.0–6.0 |
Long et al. [19] | 20 | RegenKit | stress urinary incontinence | 5.0 |
Jhang et al. [20] | 19 | not specified | bladder pain syndrome | 10.0 |